DSHEA Supplement Claims Review

The problem DSHEA claim reviews solve

Supplement brands live in a narrow compliance corridor. DSHEA permits structure-function claims on dietary supplements, which means you can say your product supports a normal function or structure in the body. You cannot say it treats, cures, mitigates, or prevents a disease. The line between the two moves with medical consensus, with regulatory interpretation, and with the specific context in which the claim appears. A product page, a blog post, a testimonial, a podcast sponsorship, an influencer caption, and a paid ad all can push a claim across the line, sometimes in combination rather than individually.

The enforcement posture is asymmetric. FDA issues warning letters that are public, reputationally damaging, and typically demand remediation within fifteen business days. FTC pursues substantiation cases that can result in consent decrees, monetary penalties, and future conduct restrictions that constrain marketing for years. State attorneys general pursue false advertising cases under state consumer protection law. Class action plaintiffs' firms pursue cases under state false advertising and warranty law. Each has its own bar, its own evidentiary standard, and its own remedy. A brand needs to pass all of them simultaneously.

The operational problem is that claim creation is distributed. A product page copywriter writes a structure-function claim. A blog writer elaborates with a disease-adjacent example. A paid social copywriter shortens it to fit a headline character limit and loses the qualifier. An influencer improvises in a video. A customer service agent quotes a testimonial in an email. Each individual decision is small. The aggregate exposure is not. A DSHEA review is the exercise of imposing a consistent claim discipline across every surface the brand speaks on.

Our approach

We run a four week DSHEA claims review. We work alongside the brand's regulatory counsel rather than replacing it, and our deliverables are written to be defensible to counsel review.

Step one is the claim inventory. We document every claim made about every product across every surface: product pages, collection descriptions, blog posts, email campaigns for the past six months, SMS campaigns, paid ads active or recently active, PDP reviews prominently featured, podcast sponsorships, and influencer content where we have access. We categorize each claim as structure-function, general health, disease-adjacent, or disease.

Step two is the substantiation review. For every structure-function claim we confirm whether competent and reliable scientific evidence supports it. For ingredient-level claims we review the monograph, the published literature, and any brand-specific studies. For formula-level claims we verify the claim is appropriate given the formula composition and dosage. Inadequate substantiation is itself a finding even when the claim is technically permissible.

Step three is the disclaimer and placement review. DSHEA structure-function claims require the FDA disclaimer stating the statement has not been evaluated by FDA and the product is not intended to diagnose, treat, cure, or prevent any disease. We verify disclaimer presence, placement, and readability across every surface. We verify FDA notification status for claims requiring it.

Step four is the cross-platform policy review. Amazon supplement listing policies, Meta Ads policies, TikTok policies, Google Ads policies, and podcast hosting policies each layer additional requirements. We audit against each applicable policy.

Step five is the program build. Claim discipline is a process, not a one-time audit. We deliver a claim approval workflow, a pre-publication review checklist, an influencer brief template with compliance language, and a quarterly re-audit cadence. We train the marketing team on the workflow.

What you get

▸ Claim inventory covering every surface the brand speaks on. ▸ Claim categorization as structure-function, general health, disease-adjacent, or disease. ▸ Substantiation file per claim with supporting literature references. ▸ FDA notification review and filing recommendation for new claims. ▸ Disclaimer placement review across every surface with remediation steps. ▸ Amazon, Meta, TikTok, and Google Ads policy conformance review. ▸ Influencer and affiliate content audit with brief template update. ▸ Claim approval workflow document with assigned reviewers. ▸ Pre-publication review checklist embedded in the content production process. ▸ Quarterly re-audit calendar with trigger-based reviews for new product launches. ▸ Training session for marketing, creative, and customer service teams.

Timeline

Four weeks in three phases.

Week one is claim inventory and categorization across every surface.

Weeks two and three are substantiation review, disclaimer review, and platform policy review.

Week four is the program build, remediation roadmap, and training.

Mini case anatomy

A supplement brand in the fifteen to twenty-five million revenue range received an FDA warning letter citing eleven claims across their product pages and blog. The claims had been written over a two year period by three different copywriters without formal review. Seven of the eleven were disease claims in substance if not in explicit wording. The letter demanded remediation within fifteen business days.

We ran the audit in three compressed weeks. The claim inventory identified forty-seven claims beyond the eleven cited by FDA that presented similar risk. Substantiation review identified nine structure-function claims with inadequate scientific support that needed either reformulation language or claim retirement. Influencer content review identified recurring disease-adjacent framing that had been imputed to the brand.

The warning letter response documented remediation within the required window. The FDA closed the file six months later without escalation. The brand implemented the claim approval workflow and the quarterly re-audit cadence. No subsequent warning letters have arrived. Annual comprehensive review plus quarterly surface-specific re-audit has become the standard cadence.

FAQs

See frequently asked questions below. DSHEA review sits alongside broader marketing claim substantiation for non-supplement brands, covered in our claim substantiation leaf. Supplement brands also typically need our privacy compliance audit and SMS TCPA compliance review. For the broader picture see our compliance audits hub and our WCAG accessibility audit.